Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine-assisted Group Therapy for Spanish-speaking Adults With Depression
NCT06597695Phase 2Recruiting
- Start
- Jul 2025
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in major depressive disorder (MDD). Started Jul 2025; status: recruiting.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06597695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06597695.